Article Contents ::
- 1 Details About Generic Salt :: Docusate
- 2 Main Medicine Class:: Laxative,Fecal softener
- 3 (DOCK-you-sate) Docusate Sodium (Dioctyl Sodium Sulfosuccinate; DSS) Colace, Diocto, Docu, D.O.S, D-S-S, ex-lax Stool Softener, Genasoft, Modane Soft, Non-Habit Forming Stool Softener, Phillips’ Liqui-Gels, Regulax SS, Silace, Stool Softener, PMS-Docusate Sodium, Regulex, Selax, Soflax Docusate Calcium (Dioctyl Calcium Sulfosuccinate) DC Softgels, Stool Softener, Stool Softener DC, Surfak Liquigels, Albert Docusate, PMS-Docusate Calcium, Surfak Docusate Potassium (Dioctyle Potassium Sulfosuccinate) Dialose, Diocto-K, Kasof, Perestan Class: Laxative/Fecal softener
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Docusate
Main Medicine Class:: Laxative,Fecal softener
(DOCK-you-sate)
Docusate Sodium (Dioctyl Sodium Sulfosuccinate; DSS)
Colace, Diocto, Docu, D.O.S, D-S-S, ex-lax Stool Softener, Genasoft, Modane Soft, Non-Habit Forming Stool Softener, Phillips’ Liqui-Gels, Regulax SS, Silace, Stool Softener, PMS-Docusate Sodium, Regulex, Selax, Soflax
Docusate Calcium (Dioctyl Calcium Sulfosuccinate)
DC Softgels, Stool Softener, Stool Softener DC, Surfak Liquigels, Albert Docusate, PMS-Docusate Calcium, Surfak
Docusate Potassium (Dioctyle Potassium Sulfosuccinate)
Dialose, Diocto-K, Kasof, Perestan
Class: Laxative/Fecal softener
Drugs Class ::
Action Facilitates stool softening by detergent activity.
Indications for Drugs ::
Indications Short-term treatment of constipation; prophylaxis in patients who should not strain during defecation (eg, after anorectal surgery, myocardial infarction); evaquate the colon for rectal and bowel examinations; prevention of dry hard stools.
Drug Dose ::
Route/Dosage
DOCUSATE SODIUM
ADULTS & CHILDREN > 12 YR: PO 50 to 500 mg. CHILDREN 6 to 12 YR: PO 40 to 120 mg. CHILDREN 3 to 6 YR: PO 20 to 60 mg. CHILDREN < 3 YR: PO 10 to 40 mg.
DOCUSATE CALCIUM
ADULTS: PO 240 mg. CHILDREN ³ 6 YR & Adults With MINIMAL NEEDS: PO 50 to 150 mg.
DOCUSATE POTASSIUM
ADULTS: PO 100 to 300 mg. CHILDREN ³ 6 YR: PO 100 mg at bedtime.
Contraindication ::
Contraindications Nausea, vomiting or other symptoms of appendicitis; acute surgical abdomen; fecal impaction; intestinal obstruction; undiagnosed abdominal pain; co-administration with mineral oil.
Drug Precautions ::
Precautions
Pregnancy: Category C. Lactation: Undetermined. Abuse/dependence: Long-term use may lead to laxative dependence, fluid and electrolyte imbalances, steatorrhea, osteomalacia and vitamin and mineral deficiencies. Fluid and electrolyte imbalance: Excessive laxative use may lead to significant fluid and electrolyte imbalance. Rectal bleeding or failure to respond: May indicate serious condition that may require further medical attention. Concomitant laxative use: Do not use other laxatives, especially during the initial phase of therapy for portal-systemic encephalopathy; the resulting loose stools may falsely suggest adequate lactulose dosage.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Palpitations. CNS: Dizziness; fainting. GI: Excessive bowel activity (griping, diarrhea, nausea, vomiting); perianal irritation; bloating; flatulence; abdominal cramping. OTHER: Sweating; weakness.
Drug Mode of Action ::
Action Facilitates stool softening by detergent activity.
Drug Interactions ::
Interactions
Mineral oil: Docusate may increase absorption of mineral oil from GI tract, leading to toxicity.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies.
- Assess patient’s bowel regimen to determine nonpharmacologic interventions for bowel evacuation.
- Review patient’s diet history for medical restriction of sodium. If sodium restriction is present, docusate sodium should not be used.
- Document daily I&O.
- Evaluate and document patient’s response to stool softener, noting and reporting any adverse reactions such as nausea, vomiting, abdominal cramping or diarrhea.
- Monitor patient frequently for signs and symptoms of dehydration and electrolyte imbalance such as weakness, dizziness, confusion, palpitations, thirst or decreased urine output.
Drug Storage/Management ::
Administration/Storage
- Administer each dose with full glass of water.
- Do not open or otherwise alter capsules.
- Do not give within 1 hr of other drugs or antacids, milk or histamine H2 blockers.
- Do not administer for > 1 wk without follow-up evaluation.
- Store capsules at room temperature. Protect liquid preparations from light.
Drug Notes ::
Patient/Family Education
- Tell patient to drink full glass of water with each dose.
- Instruct patient to swallow tablets whole and not to chew them.
- Instruct patient not to use mineral oil while taking this drug.
- Teach patient other methods of stimulating regular bowel evacuation: attempt to evacuate bowels at same time each day; drink 6 to 8 full glasses of water; eat high-fiber diet; exercise daily; respond to urge for bowel movement as soon as possible.
- Explain that liquid forms, excluding syrup, may be mixed with fruit juice or milk to mask unpleasant taste.